Expansion announcement set to make Hydropothecary one of the top cannabis producers in the country
Cannabis News
Liberals reach deal with the provinces on sharing pot tax revenue
Agreement gives provinces at least 70% of tax revenues from legal cannabis sales
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Sets its Sights on Booming Global Cannabis Industry
The technology also eliminates the need for co-administration with unhealthy sugars or sweeteners in delivery that are commonly used to mask the bitter tastes.
EVIO, Inc. (EVIO) Signs Non-Binding LOI to Acquire Licensed Cannabis Laboratory in Berkeley, CA
EVIO (OTCQB: EVIO) this morning announced that it has signed a non-binding Letter of Intent (“LOI”) to acquire 60% of C3 Labs, LLC.
Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Develops Cannabis-Based Therapeutics in Response to Opioid Epidemic
Emerging pharmaceutical and IP development company Veritas Pharma (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) is using scientific research and development to stake out its spot in the medical marijuana industry.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Utilizes Proprietary Advanced Biosynthesis Process to Develop Cannabinoids-based Therapies
InMed remains focused on discovering potential breakthrough cannabinoid-based therapies by utilizing its proprietary cannabinoid biosynthesis process and its bioinformatics drug and disease targeting tool.
Aurora Cannabis Rebuts CanniMed's Call for Government Intervention to Block Takeover Bid
Saskatchewan Government Rejects CanniMed CEO's Plea. Aurora Intends to Establish Medical Cannabis Centre of Excellence in Saskatchewan
TerrAscend closes $52,500,000 private placement financing
TerrAscend Corp. (CSE: TER) announces that it has closed the previously announced non-brokered private placement whereby funds advised by JW Asset Management, LLC, Canopy Growth Corporation and Canopy Rivers Corporation acquired from TerrAscend, an aggregate of 47,727,273 units of the Company at a price per unit of $1.10 for aggregate gross proceeds of approximately $52,500,000.
MPX Bioceutical Receives Both Municipal and State Approval for GreenMart of Nevada NLV License Transfer
MPX Bioceutical Corporation (CSE:MPX) (OTC:MPXEF) today announced that the Company, through its wholly-owned U.S. subsidiary, CGX Life Sciences Inc., has been granted both Municipal and State approval for the license transfer of GreenMart of Nevada NLV, LLC, an award winning licensed cultivation, production and wholesale business located in Las Vegas, Nevada.
Newfoundland & Labrador and Canopy Growth Enter Comprehensive Supply, Development and Retail Agreement
Canopy Growth announces that the Company has entered into a supply and production agreement with the Province of Newfoundland and Labrador, the largest provincial cannabis supply agreement announced to date, securing a regulated supply of cannabis for Newfoundlanders and Labradorians heading into the legal adult access market.
Skinvisible, Inc. (SKVI) Poised for Growth More than Skin Deep
Skinvisible (OTCQB: SKVI) is poised for growth in the booming global topical drug delivery market.
SeeThruEquity Updates Coverage on PotNetwork Holding, Inc. (POTN)
SeeThruEquity recently issued a company update and price target of $0.40 on shares of PotNetwork Holding, Inc.’s (OTC: POTN) stock.
Colorado Harvest Company’s Director of Retail Sales Brings Williams-Sonoma Taste, J. Crew Style and Eddie Bauer Adventure to Create World Class Cannabis Shopping Experiences
Colorado Harvest Company, a vertically integrated cannabis business with three dispensaries, hired Laurie Bosch as director of retail sales to strengthen its national brand by creating exciting and differentiated shopping experiences for cannabis enthusiasts in Colorado.
Grey Cloak Tech Inc. (GRCK) Targets Massive CBD Market Through Eqova Life Sciences Subsidiary
Grey Cloak Tech (OTCQB: GRCK) is positioning itself to profit from the growing cannabinoid (“CBD”) market through its wholly owned subsidiary Eqova Life Sciences.
Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Retains Medical Director to Advise Cannabis Research Programs
Veritas Pharma (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) this morning reported that the company has hired Dr. M. Scott Alexander as a medical director.